CSRC Continues To Drive Impact
Check out our latest paper ‘Cardiovascual Safety in Oncology Clinical Trials: JACC: CardioOnCology Primer” and get guidance how:
- Improved cardiovascular event definitions should be used in cancer therapy trials:
- Refinements in safety data ascertainment methods should allow better characterization of potential treatment-associated toxicities
- Optimal cardiovascular event ascertainment and recording methods may very depending on the drug, development stage, and patient factors.
Check out our latest paper here: https://www.jacc.org/doi/epdf/10.1016/j.jaccao.2024.09.014